A61K 31/7008
Compounds having an amino group directly attached to a carbon atom of
Official title: Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
A61K31/7008 (Compounds having an amino group directly attached to a carbon atom of) appears on 479 US grants and 955 published applications in this corpus.
Search patents in A61K- Granted patents
- 479
- Published applications
- 955
- Assignees
- 449
- Inventors
- 1,436
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 6 | 7 |
| 2002 | 8 | 25 |
| 2003 | 18 | 34 |
| 2004 | 8 | 40 |
| 2005 | 16 | 35 |
| 2006 | 14 | 53 |
| 2007 | 10 | 56 |
| 2008 | 8 | 35 |
| 2009 | 9 | 29 |
| 2010 | 18 | 36 |
| 2011 | 18 | 42 |
| 2012 | 14 | 23 |
| 2013 | 19 | 35 |
| 2014 | 28 | 44 |
| 2015 | 31 | 54 |
| 2016 | 23 | 50 |
| 2017 | 35 | 49 |
| 2018 | 24 | 41 |
| 2019 | 33 | 44 |
| 2020 | 17 | 32 |
| 2021 | 30 | 45 |
| 2022 | 20 | 35 |
| 2023 | 13 | 39 |
| 2024 | 17 | 21 |
| 2025 | 12 | 30 |
| 2026 | 11 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method of treating viral infections with hexose type monosaccharides and analogs thereof15 Sep 2026US 12,734,185 B2Board of Regents, The University of Texas System
- Tetrahydrocurcuminoid-metal complexes, manufacturing methods thereof, and uses thereof1 Sep 2026US 12,721,831 B2Probioticsmart, LLC
- Bifunctional degraders of galactose-deficient immunoglobulins7 Jul 2026US 12,673,111 B2Biohaven Therapeutics Ltd.
- POSS viscoelastic hemostatic agents2 Jun 2026US 12,642,886 B2Hybrid Plastics, Inc.
- Treatment of Fabry disease in ERT-naïve and ERT-experienced patients14 Apr 2026US 12,599,594 B2Amicus Therapeutics, Inc.
- Antiviral infusion composition8 Oct 2026US 2026/0306518 A1
- Methods for developing companion supplements for dogs, related compositions, and systems17 Sep 2026US 2026/0272876 A1Life's Abundance
- Targeting Lignums30 Jul 2026US 2026/0218176 A1Arrowhead Pharmaceuticals, Inc.
- Use of glycogen metabolism inhibitors for the treatment of cancer16 Jul 2026US 2026/0199289 A1University of Vermont and State Agricultural College
- Methods of treating inflammation9 Jul 2026US 2026/0191887 A1Therapeutikos, Inc.
Most cited
By later US patents
- Chondroprotective/restorative compositions and methods of use thereof140US 6,924,273 B22005
- Systems, devices, and methods for making or administering frozen particles96US 8,256,233 B2The Invention Science Fund I, LLC · 2012
- N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use90US 6,159,485 AYuGenic Limited Partnership · 2000
- Glucosamine, chondroitin and manganese composition for the protection and repair of connective tissue87US 5,364,845 ANutramax Laboratories, Inc. · 1994
- Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue82US 5,587,363 ANutramax Laboratories, Inc. · 1996